Brain substrate metabolism and ß-cell function in humans: A positron emission tomography study

dc.contributor.authorEleni Rebelos
dc.contributor.authorAndrea Mari
dc.contributor.authorMarco Bucci
dc.contributor.authorMiikka‐Juhani Honka
dc.contributor.authorJarna C. Hannukainen
dc.contributor.authorKirsi A. Virtanen
dc.contributor.authorJussi Hirvonen
dc.contributor.authorLauri Nummenma
dc.contributor.authorMartin Heni
dc.contributor.authorPatricia Iozzo
dc.contributor.authorEle Ferrannini
dc.contributor.authorPirjo Nuutila
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=kuvantaminen ja kliininen diagnostiikka|en=Imaging and Clinical Diagnostics|
dc.contributor.organizationfi=lääketieteellinen tiedekunta|en=Faculty of Medicine|
dc.contributor.organizationfi=psykologia|en=Psychology|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.13290506867
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.contributor.organization-code1.2.246.10.2458963.20.15586825505
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code1.2.246.10.2458963.20.69079168212
dc.contributor.organization-code2609810
dc.converis.publication-id48850861
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/48850861
dc.date.accessioned2022-10-28T14:07:38Z
dc.date.available2022-10-28T14:07:38Z
dc.description.abstract<p>Aims</p><p>Recent clinical studies have shown enhanced brain glucose uptake during clamp and brain fatty acid uptake in insulin‐resistant individuals. Preclinical studies suggest that the brain may be involved in the control of insulin secretion. The aim of this study was to investigate whether brain metabolism assessed as brain glucose and fatty acid uptake is associated with the parameters of β‐cell function in humans.</p><p>Materials and methods<br /></p><p>We analysed cross‐sectional data of 120 subjects across a wide range of BMI and insulin sensitivity. Brain glucose uptake (BGU) was measured during euglycaemic‐hyperinsulinaemic clamp (n = 67) and/or during fasting (n = 45) using [18F]‐fluorodeoxyglucose (FDG) positron emission tomography (PET). In another group of subjects (n = 34), brain fatty acid uptake was measured using [18F]‐fluoro‐6‐thia‐heptadecanoic acid (FTHA) PET during fasting. The parameters of β‐cell function were derived from OGTT modelling. Statistical analysis was performed with whole‐brain voxel‐based statistical parametric mapping.</p><p>Results<br /></p><p>In non‐diabetics, BGU during euglycaemic hyperinsulinaemic clamp correlated positively with basal insulin secretion rate (r = 0.51, P = .0008) and total insulin output (r = 0.51, P = .0008), whereas no correlation was found in type 2 diabetics. BGU during clamp correlated positively with potentiation in non‐diabetics (r = 0.33, P = .02) and negatively in type 2 diabetics (r = −0.61, P = .02). The associations in non‐diabetics were not explained with whole‐body insulin sensitivity or BMI. No correlations were found between baseline (fasting) BGU and basal insulin secretion rate, whereas baseline brain fatty acid uptake correlated directly with basal insulin secretion rate (r = 0.39, P = .02) and inversely with potentiation (r = −0.36, P = .04).</p><p>Conclusions<br /></p><p>Our study provides coherent, though correlative, evidence that, in humans, the brain may be involved in the control of insulin secretion independently of insulin sensitivity.</p><div><br /></div>
dc.identifier.eissn2398-9238
dc.identifier.jour-issn2398-9238
dc.identifier.olddbid186423
dc.identifier.oldhandle10024/169517
dc.identifier.urihttps://www.utupub.fi/handle/11111/38501
dc.identifier.urnURN:NBN:fi-fe2021042825208
dc.language.isoen
dc.okm.affiliatedauthorRebelos, Eleni
dc.okm.affiliatedauthorBucci, Marco
dc.okm.affiliatedauthorHonka, Miikka
dc.okm.affiliatedauthorHannukainen, Jarna
dc.okm.affiliatedauthorVirtanen, Kirsi
dc.okm.affiliatedauthorHirvonen, Jussi
dc.okm.affiliatedauthorNummenmaa, Lauri
dc.okm.affiliatedauthorIozzo, Patricia
dc.okm.affiliatedauthorNuutila, Pirjo
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWiley-Blackwell Publishing Ltd
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumbere00136
dc.relation.doi10.1002/edm2.136
dc.relation.ispartofjournalEndocrinology, Diabetes and Metabolism
dc.relation.issue3
dc.relation.volume3
dc.source.identifierhttps://www.utupub.fi/handle/10024/169517
dc.titleBrain substrate metabolism and ß-cell function in humans: A positron emission tomography study
dc.year.issued2020

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
edm2.136.pdf
Size:
1.03 MB
Format:
Adobe Portable Document Format
Description:
Publisher's version